$NKTX

Nkarta Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$18.3 β–Ό-0.489%

Extented Hours

VOLUME

551,219

DAY RANGE

17.0387 - 18.48

52 WEEK

7.55 - 37.68

Join Discuss about NKTX with like-minded investors

profile
@TraderXx #StockTraders.NET
recently

$NKTX 19.20's area of interest

87 Replies 15 πŸ‘ 10 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$NKTX when no one is looking

87 Replies 7 πŸ‘ 15 πŸ”₯

profile
@Chano #StockTraders.NET
recently

$NKTX LOD test

148 Replies 10 πŸ‘ 10 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$nktx decent curl on vwap

130 Replies 14 πŸ‘ 14 πŸ”₯

profile
@Chano #StockTraders.NET
recently

I lost sight of $NKTX what a weird action all day long

76 Replies 10 πŸ‘ 6 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

fuck...lost this off track for the long play!!! πŸ€¦β€β™‚οΈπŸ€¦β€β™‚οΈ > @soheil.n said: $NKTX - moving ...will wait for high 18s to firm before longing for 20

145 Replies 12 πŸ‘ 8 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

$NKTX - moving ...will wait for high 18s to firm before longing for 20

125 Replies 10 πŸ‘ 7 πŸ”₯

profile
@Baljit123 #StockTraders.NET
recently

COSM - Looking for a morning bounce 1.40 / 1.50 / 1.60 to short NUTX - This one has been very trappy. So best to use WAY OUTTER LINES 9.00 / 9.50 / 10.00. USE SMALL SIZE ON THIS BECAUSE IT IS VERY THIN VIVK - Looking for an SSR rebound to short into ideally 3.30 / 3.50 / 3.60 lines IDAI - Extremely hard to locate and extremely expensive to locate. I am not sure on this one yet. Maybe a 6.00 push an rejection to short, but best if it tanks at the open and we can short a bounce. More commentary at open CYN - AVOID short. If it tanks it tanks, but this has been trapping daily NKTX - AVOID short non niche XPON - Potential HOT CHICK if reclaims https://myinvestingclub.com/trading/how-to-scale-into-the-watch-list-when-to-use-max-full-size-when-trading-30-rule-watch-list/

82 Replies 12 πŸ‘ 14 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

$NKTX - looking to long for a possible macro clear out for 20 +

107 Replies 12 πŸ‘ 8 πŸ”₯

profile
@maletone #StockTraders.NET
recently

totally took $NKTX off of radar would have been a great long

77 Replies 15 πŸ‘ 6 πŸ”₯

profile
@Chano #StockTraders.NET
recently

the filing from NKTX came today $13M shares price $15

89 Replies 8 πŸ‘ 8 πŸ”₯

profile
@Chano #StockTraders.NET
recently

holy cow! $NKTX

64 Replies 15 πŸ‘ 15 πŸ”₯

profile
@maletone #StockTraders.NET
recently

sold all my $nktx

142 Replies 9 πŸ‘ 15 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$frge $nutx $nktx Wild so far

65 Replies 9 πŸ‘ 11 πŸ”₯

profile
@maletone #StockTraders.NET
recently

mostly sold $NKTX

107 Replies 12 πŸ‘ 14 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$NKTX lkets go

149 Replies 15 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$Nktx getting a lift

53 Replies 10 πŸ‘ 15 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$NKTX toast

111 Replies 12 πŸ‘ 13 πŸ”₯

profile
@maletone #StockTraders.NET
recently

with ssr $NKTx might be a decent long

132 Replies 14 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$NKTX could turn into a long

79 Replies 7 πŸ‘ 14 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$NKTX multi day runner for sure

59 Replies 9 πŸ‘ 6 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

$NKTX - type 4 ...flushed key level and then fast reclaim:

95 Replies 8 πŸ‘ 10 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

$NKTX - incoming as well...nhod

125 Replies 8 πŸ‘ 9 πŸ”₯

profile
@maletone #StockTraders.NET
recently

got that flush on $nktx

99 Replies 14 πŸ‘ 13 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

$NKTX - 4th FBO in the making? if 16.4s-.5s firms up

126 Replies 9 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

I'm probably done with $NKTX on the day

105 Replies 9 πŸ‘ 15 πŸ”₯

profile
@Chano #StockTraders.NET
recently

$NKTX paper for everyone! get in line!

139 Replies 15 πŸ‘ 10 πŸ”₯

profile
@Chano #StockTraders.NET
recently

there is it > @Chano said: possible fbo $NKTX

128 Replies 9 πŸ‘ 8 πŸ”₯

profile
@Chano #StockTraders.NET
recently

possible fbo $NKTX

60 Replies 6 πŸ‘ 13 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$nktx pretty gnarly tbh. wasn't expecting that

64 Replies 8 πŸ‘ 12 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

and now have restrictions in place on $NKTX, $SKYH and many other names from last week...so not much to do for me

104 Replies 11 πŸ‘ 8 πŸ”₯

profile
@Chano #StockTraders.NET
recently

$NKTX oooh my!

92 Replies 14 πŸ‘ 12 πŸ”₯

profile
@Chano #StockTraders.NET
recently

14.15s strong support buyer $NKTX

132 Replies 6 πŸ‘ 10 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

$NKTX - need 14.2s to top out

147 Replies 7 πŸ‘ 15 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

$NKTX - ss small avg 14.8

147 Replies 7 πŸ‘ 7 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$NKTX* I mean

85 Replies 12 πŸ‘ 14 πŸ”₯

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Friday, October 8, 2021 Futures Up/Down % Last Dow 42.00 0.12% 34,678 S&P 500 2.50 0.06% 4,392 Nasdaq 0.00 0.00% 14,881 After a week of overnight swings and market volatility, U.S. futures come into Friday’s trading looking flat, with the S&P little changed at 4,390 after a strong session on Thursday was met with a late day pullback, as major averages finished well off their best levels. U.S. futures steady as investors anticipate a key employment report that could offer clues on the Fed’s timeline for reducing bond purchases. Nonfarm payroll data at 8:30 AM with an est. for +500K jobs added, private payrolls est. +455K, manufacturing payrolls +25K and the unemployment rate to fall to 5.1% from 5.2%; average hourly earnings expected to rise +0.4% (vs. last month +0.6%). Equities rose and Treasuries sank on Thursday after Senate leaders pulled the U.S. from the brink of default with a deal for a short-term debt ceiling increase in the amount of $480B to a $28.9 trillion debt limit. However, this could be short lived as the agreement only funds Treasury debt until Dec. 3, meaning Senators will again face a deadline for default. In Asian markets, the Shanghai Index opened for trading after a week long pause to celebrate its Golden Week holiday, rising 24 points to 3,592, the Hang Seng Index gained 136 points to 24,837 and the Nikkei advanced 370 points (1.34%) to 28,048. In Europe, the German DAX is down a few points at 15,235, while the FTSE 100 is up a few at 7,085. Oil prices are higher, heading for its seventh weekly gain with WTI crude nearing $80 Market Closing Prices Yesterday The S&P 500 Index gained 36.21 points, or 0.83%, to 4,399.76 The Dow Jones Industrial Average rose 337.95 points, or 0.98%, to 34,754.94 The Nasdaq Composite surged 152.10 points, or 1.05%, to 14,654.02 The Russell 2000 Index advanced 35.14 points, or 1.59% to 2,250.09 Events Calendar for Today 8:30 AM ET Non-Farm Payrolls for September…est. +500K 8:30 AM ET Private Payrolls for September…est. +455K 8:30 AM ET Manufacturing Payrolls for September…est. +25K 8:30 AM ET Unemployment Rate for September…est. 5.1% 8:30 AM ET Average Hourly Earnings for September…est. +0.4% 10:00 AM ET Wholesale Inventories MoM for Aug 1:00 PM EST Baker Hughes Weekly rig count data Macro Up/Down Last Nymex 0.58 78.86 Brent 0.65 82.60 Gold 0.90 1,762.00 EUR/USD 0.0014 1.1563 JPY/USD 0.23 111.82 10-Year Note +0.021 1.593% World News The U.S. Senate on Thursday approved legislation to temporarily raise the federal government’s $28.4 trillion debt limit and avoid the risk of a historic default this month, but it put off until early December a decision on a longer-lasting remedy. German Aug Trade Balance smaller surplus: +€13.0b vs +€15.8b consensus; German August Exports lower down -1.2% vs +0.5% consensus and German Aug Imports higher rising +3.5% vs 1.8% consensus Sector News Breakdown Consumer Home Depot ($HD) and Lowe’s ($LOW) both downgraded to Hold from Buy at Loop Capital Tesla ($TSLA) CEO Elon Musk confirmed that the car maker is moving its headquarters from Fremont, California to Austin, Texas, where the company has been constructing a new factory for a little over a year. CEO Musk also said a global shortage of chips and ships is the only thing standing in the way of the company maintaining sales growth in excess of 50% Oatly Group ($OTLY) upgraded to Overweight from Neutral with a $21 price target Drive Shack ($DS) reports prelim Q3 revs of $75M vs. est. $76.74M Scientific Games ($SGMS) wins 10-year Vermont lottery systems contract; company’s advanced platforms and game services will modernize lottery play and maximize revenues for programs in green mountain state Thor Industries ($THO) increases regular quarterly dividend 5% to 43c per share Energy, Industrials and Materials Dow Transports finished the day down -0.25% just above the 14,500 level, but slipping below its 50-day MA at 14,515 B. Hunt ($JBHT) downgraded to Underweight on relative valuation at JPMorgan Union Pacific ($UNP) upgraded to Overweight from Neutral with a price target of $247, up from $234 at JPMorgan on recent selloff Sundial Growers Inc. ($SNDL) announced it will acquire liquor and pot retailer Alcanna in an all-stock deal with a total consideration of about C$346M Financials Pzena Investment Management Inc. ($PZN) prelim AUM as of Sept 30 of $50.8 bln Chubb ($CB) announced a definitive agreement to acquire the life and non-life insurance companies that house the personal accident, supplemental health and life insurance business of Cigna (CI) in seven Asia-Pacific, or APAC, markets for $5.75B in cash Healthcare Accolade Inc. ($ACCD) Q2 revs $73.3M vs. est. $70.4M; Q2 adj Ebitda loss (-$19.4M) vs. est. loss (-$21.9m); sees FY revs $303M-$307M, from prior view $300M-$305M (est. $303.4M); guides Q3 adj Ebitda loss $21.5M-$24.5M vs. est. loss $20.2M, but Q3 revs above views Quidel ($QDEL) guides Q3 revs $505M-$510M vs. est. $186.3M; says covid-19 revenues for Q3 of 2021 expected to be about $406M, compared with $375.7M YoY Allogene Therapeutics ($ALLO) shares fall over 35% after reporting the FDA put a clinical hold of Allocar T trials based on a single patient case in alpha2 trial; believes data from alpha trials demonstrates a favorable clinical profile of allo-501a Apollo EndoSurgery ($APEN) sees 3Q revs $16-16.4Mm vs est. $14.4Mm; sees 3Q net loss $6.1-7.3Mm vs est. net loss $8.3Mm BeiGene’s ($BGNE) BRUKINSA (zanubrutinib) has been approved in Australia for the treatment of adult patients with WaldenstrΓΆm’s macroglobulinemia who have received at least one prior therapy or in first line treatment for patients unsuitable for chemo-immunotherapy. Mirati Therapeutics ($MRTX) to collaborate with Sanofi ($SNY) on phase 1/2 study evaluating combination of adagrasib with a SHP2 inhibitor in KRAS g12c-mutated lung cancer Nkarta ($NKTX) provided updates on its NKX019 and NKX101 clinical development programs saying patients have been dosed in the international phase 1 trial of NKX019 in advanced B-cell malignancies IsoPlexis (ISO)333M share IPO priced at $15.00 Pyxis Oncology ($PYXS)5M share IPO priced at $16.00 Prelude Therapeutics ($PRLD) shares fall after announces presentation of encouraging data from multiple programs at the AACR-NCI-EORTC virtual international conference on molecular targets and cancer therapeutics Relay Therapeutics ($RLAY) announces interim clinical data for RLY-4008, in a first-in-human trial in patients with FGFR2-altered cholangiocarcinoma and multiple other solid tumors Technology, Media & Telecom VMware ($VMW) authorized new stock buyback program for up to $2B Samsung Electronics Co Ltd ($SSNLF) said Q3 operating profit likely jumped 28% to its highest in three years, helped by rising memory chip prices and brisk sales of its new foldable smartphones; estimated July-September profit at 15.8 trillion won ($13.3 billion) vs. est. of 16.1 trillion won. ChipMOS (IMOS) reports Q3 revenues rose 25.9% on a Y/Y basis to $257.2M (+2.6% Q/Q) vs. a consensus of $262.90M. Taiwan Semiconductor Manufacturing Co.’s ($TSM) September revenue was up 19.7% Y/Y to NT$152.69B or about $5.44B. AU Optronics ($AUOTY) reports September revenue rose 26.5% Y/Y to NT$33.0B (+0.9% M/M); Q3 revenues rose 35.3% Y/Y NT$99.05B Oracle ($ORCL), Telecom Italia, and Noovle, TIM Group’s cloud company, have signed a collaboration agreement to offer multi-cloud services for enterprises and the public sector organizations in Italy. Sirius XM ($SIRI) downgraded to Neutral from Overweight with a price target of $7, down from $8 at JPMorgan

92 Replies 15 πŸ‘ 12 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

$NKTX about to open IPO prices around 16. Read S-1 before trading

108 Replies 13 πŸ‘ 10 πŸ”₯

profile
@Benlax #droscrew
recently

no words... Nkarta $NKTX IPO Indicated to Open 200% Higher

98 Replies 14 πŸ‘ 14 πŸ”₯

Key Metrics

Market Cap

845.17 M

Beta

2.04

Avg. Volume

508.52 K

Shares Outstanding

48.66 M

Yield

0%

Public Float

0

Next Earnings Date

2022-11-09

Next Dividend Date

Company Information

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off the shelf natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, which are engineered to enhance tumor targeting and improve persistence for sustained activity in the body.

Website:

HQ: ,

Related News